バイオディフェンス市場：製品別、エンドユーザー別-2025-2030年の世界予測

バイオディフェンス市場は、2023年に183億6,000万米ドルと評価され、2024年には203億3,000万米ドルに達すると予測され、CAGR 11.25％で成長し、2030年には387億3,000万米ドルになると予測されています。

バイオディフェンスは、ウイルス、細菌、その他の病原体などの生物学的病原体による脅威から人々を守ることを目的とした、さまざまな戦略、調査、技術を包含しています。その必要性は、生物兵器、バイオテロリズム、自然発生的なアウトブレイクに対する懸念の高まりから生じており、強固な防御メカニズムの必要性が極めて重要であることを強調しています。バイオディフェンスの公開会社の用途は、公衆衛生対策、軍事防衛戦略、ヘルスケアインフラにまで及び、最終用途には政府機関、ヘルスケアプロバイダー、製薬会社、研究機関などが含まれます。バイオディフェンスの市場成長は、主に研究開発への投資の増加、政府と民間部門間の共同作業、早期発見と迅速な対応能力を強化するバイオテクノロジーの進歩によってもたらされます。ゲノムシークエンシング、AIベースの予測モデリング、ワクチン開発などの技術革新が主な機会であり、バイオディフェンスのインフラやトレーニングの改善に投資することで、これらの見通しをさらに高めることができます。しかし、研究開発コストの高さ、規制上のハードル、二重利用研究に対する倫理的懸念といった課題が大きな制約となっています。さらに、生物学的脅威の予測不可能性や複雑な地政学的状況に関する問題は、成長を複雑にする可能性があります。潜在的な機会を活用するための戦略的提言には、官民パートナーシップの促進、迅速な病原体同定のためのCRISPRのような新技術への投資の増加、情報共有と資源最適化のための国際協力の強化などが含まれます。また、合成生物学の進歩による新たな治療法の開発や、必要不可欠な医薬品の戦略的備蓄は、技術革新の機が熟している分野です。地政学的・環境的な変化の影響を受ける市場のダイナミックな性質は、継続的な適応と機敏な対応枠組みの開発を必要とします。利害関係者は、こうした限界に対処し、成長機会を活用することで、弾力的で効果的なバイオディフェンス戦略を確保し、世界の健康の安全保障と市場の持続可能性に大きく貢献することができます。バイオディフェンスの進化する性質は、最先端技術を取り入れ、生物学的脅威への世界的に協調した対応を促進する積極的なアプローチを求めています。

市場力学：急速に進化するバイオディフェンス市場の主要市場インサイトを公開

バイオディフェンス市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。こうした動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 有利な政府イニシアティブの存在
  • エボラウイルス、ジーバウイルスなど様々な病原体の流行の高まり
  • 疾病サーベイランスの重要性の高まり
• 市場抑制要因
  • 発展途上国や低開発国における市場浸透度の低さ
• 市場機会
  • 先進国における研究開発イニシアチブの高まり
  • バイオテクノロジーの技術的進歩
• 市場の課題
  • 高い時間投資と長い臨床手順

ポーターの5つの力：バイオディフェンス市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：バイオディフェンス市場における外部からの影響の把握

外部マクロ環境要因は、バイオディフェンス市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析バイオディフェンス市場における競合情勢の把握

バイオディフェンス市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスバイオディフェンス市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、バイオディフェンス市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨バイオディフェンス市場における成功への道筋を描く

バイオディフェンス市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 政府の好ましい取り組みの存在
    • エボラウイルス、ジバウイルスなどのさまざまな病原体の蔓延が拡大している
    • 疾病監視の重要性の高まり
  • 抑制要因
    • 発展途上国および後発開発途上国における市場浸透率の低さ
  • 機会
    • 先進国における調査開発への取り組みの高まり
    • バイオテクノロジーの技術進歩
  • 課題
    • 多大な時間の投資と長い臨床手順
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 バイオディフェンス市場：製品別

• 炭疽菌
• ボツリヌス中毒
• 放射線
• 天然痘

第7章 バイオディフェンス市場：エンドユーザー別

• 外来診療センター
• 病院
• 軍隊
• 調査機関

第8章 南北アメリカのバイオディフェンス市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第9章 アジア太平洋地域のバイオディフェンス市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第10章 欧州・中東・アフリカのバイオディフェンス市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第11章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Alnylam Pharmaceuticals, Inc.
• Altimmune, Inc.
• Bavarian Nordic A/S
• BDO USA, LLP
• Bharat Biotech Ltd.
• Dynport Vaccine Company by General Dynamics Information Technology
• Elusys Therapeutics, Inc. by Heat Biologics Inc.
• Emergent BioSolutions Inc.
• Evogen, Inc.
• Ichor Medical Systems, Inc.
• Pizer Inc.
• Serum Institute of India Pvt. Ltd.
• SIGA Technologies
• Soligenix, Inc.
• Xoma Corporation

LIST OF FIGURES

• FIGURE 1. BIODEFENSE MARKET RESEARCH PROCESS
• FIGURE 2. BIODEFENSE MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL BIODEFENSE MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL BIODEFENSE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL BIODEFENSE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL BIODEFENSE MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL BIODEFENSE MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL BIODEFENSE MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL BIODEFENSE MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. AMERICAS BIODEFENSE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 11. AMERICAS BIODEFENSE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. UNITED STATES BIODEFENSE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 13. UNITED STATES BIODEFENSE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC BIODEFENSE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. ASIA-PACIFIC BIODEFENSE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. EUROPE, MIDDLE EAST & AFRICA BIODEFENSE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA BIODEFENSE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. BIODEFENSE MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 19. BIODEFENSE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. BIODEFENSE MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL BIODEFENSE MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL BIODEFENSE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL BIODEFENSE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. BIODEFENSE MARKET DYNAMICS
• TABLE 7. GLOBAL BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL BIODEFENSE MARKET SIZE, BY ANTHRAX, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL BIODEFENSE MARKET SIZE, BY BOTULISM, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL BIODEFENSE MARKET SIZE, BY RADIATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL BIODEFENSE MARKET SIZE, BY SMALL POX, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL BIODEFENSE MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL BIODEFENSE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL BIODEFENSE MARKET SIZE, BY MILITARY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL BIODEFENSE MARKET SIZE, BY RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. AMERICAS BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 18. AMERICAS BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 19. AMERICAS BIODEFENSE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 20. ARGENTINA BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 21. ARGENTINA BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 22. BRAZIL BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 23. BRAZIL BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 24. CANADA BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 25. CANADA BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 26. MEXICO BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 27. MEXICO BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 28. UNITED STATES BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 29. UNITED STATES BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 30. UNITED STATES BIODEFENSE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 31. ASIA-PACIFIC BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 32. ASIA-PACIFIC BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 33. ASIA-PACIFIC BIODEFENSE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 34. AUSTRALIA BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 35. AUSTRALIA BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 36. CHINA BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 37. CHINA BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 38. INDIA BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 39. INDIA BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 40. INDONESIA BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 41. INDONESIA BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 42. JAPAN BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 43. JAPAN BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 44. MALAYSIA BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 45. MALAYSIA BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 46. PHILIPPINES BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 47. PHILIPPINES BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 48. SINGAPORE BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 49. SINGAPORE BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 50. SOUTH KOREA BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 51. SOUTH KOREA BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 52. TAIWAN BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 53. TAIWAN BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 54. THAILAND BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 55. THAILAND BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 56. VIETNAM BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 57. VIETNAM BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 58. EUROPE, MIDDLE EAST & AFRICA BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 59. EUROPE, MIDDLE EAST & AFRICA BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 60. EUROPE, MIDDLE EAST & AFRICA BIODEFENSE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 61. DENMARK BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 62. DENMARK BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 63. EGYPT BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 64. EGYPT BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 65. FINLAND BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 66. FINLAND BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 67. FRANCE BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 68. FRANCE BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 69. GERMANY BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 70. GERMANY BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 71. ISRAEL BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 72. ISRAEL BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 73. ITALY BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 74. ITALY BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 75. NETHERLANDS BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 76. NETHERLANDS BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 77. NIGERIA BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 78. NIGERIA BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 79. NORWAY BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 80. NORWAY BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 81. POLAND BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 82. POLAND BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 83. QATAR BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 84. QATAR BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 85. RUSSIA BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 86. RUSSIA BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 87. SAUDI ARABIA BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 88. SAUDI ARABIA BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 89. SOUTH AFRICA BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 90. SOUTH AFRICA BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 91. SPAIN BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 92. SPAIN BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 93. SWEDEN BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 94. SWEDEN BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 95. SWITZERLAND BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 96. SWITZERLAND BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 97. TURKEY BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 98. TURKEY BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 99. UNITED ARAB EMIRATES BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 100. UNITED ARAB EMIRATES BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 101. UNITED KINGDOM BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 102. UNITED KINGDOM BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 103. BIODEFENSE MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 104. BIODEFENSE MARKET, FPNV POSITIONING MATRIX, 2023

The Biodefense Market was valued at USD 18.36 billion in 2023, expected to reach USD 20.33 billion in 2024, and is projected to grow at a CAGR of 11.25%, to USD 38.73 billion by 2030.

Biodefense encompasses a range of strategies, research, and technologies aimed at protecting populations against threats from biological agents like viruses, bacteria, and other pathogens. Its necessity arises from growing concerns over biological warfare, bioterrorism, and naturally occurring outbreaks, underscoring the critical need for robust defense mechanisms. Applications of biodefense extend to public health preparedness, military defense strategies, and healthcare infrastructure, while its end-use scope includes government agencies, healthcare providers, pharmaceutical companies, and research institutions. Market growth in biodefense is primarily driven by increasing investment in R&D, collaborative efforts between government and private sectors, and advancements in biotechnology which enhance early detection and rapid response capabilities. Technological innovations such as genomic sequencing, AI-based predictive modeling, and vaccine development represent key opportunities, while investment in improving biodefense infrastructure and training can further enhance these prospects. However, challenges such as high R&D costs, regulatory hurdles, and ethical concerns over dual-use research pose significant limitations. Furthermore, issues related to the unpredictability of biological threats and the complex geopolitical landscape can complicate growth. Strategic recommendations to leverage potential opportunities include fostering public-private partnerships, increasing investment in emerging technologies like CRISPR for rapid pathogen identification, and enhancing international collaboration for information sharing and resource optimization. Exploring advancements in synthetic biology for developing novel countermeasures and strategic stockpiling of essential medical supplies are areas ripe for innovation. The market's dynamic nature, affected by geopolitical and environmental shifts, necessitates continuous adaptation and development of agile response frameworks. By addressing these limitations and capitalizing on growth opportunities, stakeholders can ensure resilient and effective biodefense strategies, making substantial contributions to global health security and market sustainability. The evolving nature of biodefense calls for a proactive approach in embracing cutting-edge technology and fostering a globally coordinated response to biological threats.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Biodefense Market

The Biodefense Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Presence of favorable government initiatives
  • Growing prevalence of various agents such as Ebola virus, Ziva virus, and others
  • Increasing importance of disease surveillance
• Market Restraints
  • Low market penetration in developing and underdeveloped countries
• Market Opportunities
  • Rising initiatives for research & developments in developed countries
  • Technological advancement in biotechnology
• Market Challenges
  • High time investment and longer clinical procedures

Porter's Five Forces: A Strategic Tool for Navigating the Biodefense Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Biodefense Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Biodefense Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Biodefense Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Biodefense Market

A detailed market share analysis in the Biodefense Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Biodefense Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Biodefense Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Biodefense Market

A strategic analysis of the Biodefense Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Biodefense Market, highlighting leading vendors and their innovative profiles. These include Alnylam Pharmaceuticals, Inc., Altimmune, Inc., Bavarian Nordic A/S, BDO USA, LLP, Bharat Biotech Ltd., Dynport Vaccine Company by General Dynamics Information Technology, Elusys Therapeutics, Inc. by Heat Biologics Inc., Emergent BioSolutions Inc., Evogen, Inc., Ichor Medical Systems, Inc., Pizer Inc., Serum Institute of India Pvt. Ltd., SIGA Technologies, Soligenix, Inc., and Xoma Corporation.

Market Segmentation & Coverage

This research report categorizes the Biodefense Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Anthrax, Botulism, Radiation, and Small Pox.
• Based on End-User, market is studied across Ambulatory Care Centers, Hospitals, Military, and Research Organizations.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Presence of favorable government initiatives
    • 5.1.1.2. Growing prevalence of various agents such as Ebola virus, Ziva virus, and others
    • 5.1.1.3. Increasing importance of disease surveillance
  • 5.1.2. Restraints
    • 5.1.2.1. Low market penetration in developing and underdeveloped countries
  • 5.1.3. Opportunities
    • 5.1.3.1. Rising initiatives for research & developments in developed countries
    • 5.1.3.2. Technological advancement in biotechnology
  • 5.1.4. Challenges
    • 5.1.4.1. High time investment and longer clinical procedures
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Biodefense Market, by Product

• 6.1. Introduction
• 6.2. Anthrax
• 6.3. Botulism
• 6.4. Radiation
• 6.5. Small Pox

7. Biodefense Market, by End-User

• 7.1. Introduction
• 7.2. Ambulatory Care Centers
• 7.3. Hospitals
• 7.4. Military
• 7.5. Research Organizations

8. Americas Biodefense Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Biodefense Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Biodefense Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Alnylam Pharmaceuticals, Inc.
• 2. Altimmune, Inc.
• 3. Bavarian Nordic A/S
• 4. BDO USA, LLP
• 5. Bharat Biotech Ltd.
• 6. Dynport Vaccine Company by General Dynamics Information Technology
• 7. Elusys Therapeutics, Inc. by Heat Biologics Inc.
• 8. Emergent BioSolutions Inc.
• 9. Evogen, Inc.
• 10. Ichor Medical Systems, Inc.
• 11. Pizer Inc.
• 12. Serum Institute of India Pvt. Ltd.
• 13. SIGA Technologies
• 14. Soligenix, Inc.
• 15. Xoma Corporation